SolasCure

About:

Transforming chronic wound care with breakthrough enzymatic technology

Twitter/X: solascure

Top Investors: European Innovation Council, Innovate UK, EIC Accelerator, Development Bank of Wales, Jonathan Milner

Description:

SolasCure is a biotechnology / biopharma company developing a breakthrough in wound bed preparation for patients with chronic wounds

Total Funding Amount:

26.3M GBP

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2017-06-20

Contact Email:

info(AT)solascure.com

Founders:

Benjamin Newmark, Sam Bakri

Number of Employees:

11-50

Last Funding Date:

2024-03-20

IPO Status:

Private

Industries: